New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study uncovers how the gut's microbiome boosts immune development

Study uncovers how the gut's microbiome boosts immune development

by Betty Zou,University of TorontoArthur Mortha, left, and Pailin Chiaranunt led new research that unveils new insights into how our resident gut microbes influence immune development. Credit: M
Gastroenterology January 24,2024
Study uncovers how the gut's microbiome boosts immune development

Study uncovers how the gut's microbiome boosts immune development

by Betty Zou,University of TorontoArthur Mortha, left, and Pailin Chiaranunt led new research that unveils new insights into how our resident gut microbes influence immune development. Credit: M
Gastroenterology January 24,2024
Risk assessment after severe complication of liver cirrhosis improved

Risk assessment after severe complication of liver cirrhosis improved

byMedical University of ViennaGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.10.007Approximately half of patients with advanced liver disease have v
Gastroenterology January 24,2024
Risk assessment after severe complication of liver cirrhosis improved

Risk assessment after severe complication of liver cirrhosis improved

byMedical University of ViennaGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.10.007Approximately half of patients with advanced liver disease have v
Gastroenterology January 24,2024
Researchers find gut microbes can affect COVID vaccine response

Researchers find gut microbes can affect COVID vaccine response

byKarolinska InstitutetChanges in alpha diversity and bacterial genus from fecal samples collected at the baseline, to predict spike IgG titers in individuals. a Study design. b Alpha diversity
Gastroenterology January 24,2024
Researchers find gut microbes can affect COVID vaccine response

Researchers find gut microbes can affect COVID vaccine response

byKarolinska InstitutetChanges in alpha diversity and bacterial genus from fecal samples collected at the baseline, to predict spike IgG titers in individuals. a Study design. b Alpha diversity
Gastroenterology January 24,2024
Researchers identify why cancer immunotherapy can cause colitis

Researchers identify why cancer immunotherapy can cause colitis

by Nicole Fawcett,University of MichiganStudies in mice reveal the mechanism that induces this severe side effect and point to a solution that kills the cancer without causing gastrointestinal i
Gastroenterology January 24,2024
Researchers identify why cancer immunotherapy can cause colitis

Researchers identify why cancer immunotherapy can cause colitis

by Nicole Fawcett,University of MichiganStudies in mice reveal the mechanism that induces this severe side effect and point to a solution that kills the cancer without causing gastrointestinal i
Gastroenterology January 24,2024
Advanced neoplasia risk found to increase at upper range of negative FIT values

Advanced neoplasia risk found to increase at upper range of negative FIT values

by Elana GotkineIndividuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online
Gastroenterology January 24,2024
Advanced neoplasia risk found to increase at upper range of negative FIT values

Advanced neoplasia risk found to increase at upper range of negative FIT values

by Elana GotkineIndividuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online
Gastroenterology January 24,2024
FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adultsby Lori SolomonThe U.S. Food and Drug Administration has approvedVelsipity(etrasimod) for adults with moderately t
Gastroenterology January 24,2024
FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adultsby Lori SolomonThe U.S. Food and Drug Administration has approvedVelsipity(etrasimod) for adults with moderately t
Gastroenterology January 24,2024
Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer developmentbyUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public Doma
Gastroenterology January 24,2024
Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer developmentbyUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public Doma
Gastroenterology January 24,2024
Doctors discover many inflammatory bowel disease patients screen positive for malnutrition

Doctors discover many inflammatory bowel disease patients screen positive for malnutrition

Doctors discover many inflammatory bowel disease patients screen positive for malnutritionbyUniversity of North Carolina Health CareAnne Peery, MD, MSCR, associate professor of medicine, UNC Sch
Gastroenterology January 24,2024
Doctors discover many inflammatory bowel disease patients screen positive for malnutrition

Doctors discover many inflammatory bowel disease patients screen positive for malnutrition

Doctors discover many inflammatory bowel disease patients screen positive for malnutritionbyUniversity of North Carolina Health CareAnne Peery, MD, MSCR, associate professor of medicine, UNC Sch
Gastroenterology January 24,2024
New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer

New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer

New inflammatory mechanisms unveiled in the setting of liver disease and liver cancerbyUniversity of BirminghamCredit:iScience(2023). DOI: 10.1016/j.isci.2023.107966An international
Gastroenterology January 24,2024
New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer

New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer

New inflammatory mechanisms unveiled in the setting of liver disease and liver cancerbyUniversity of BirminghamCredit:iScience(2023). DOI: 10.1016/j.isci.2023.107966An international
Gastroenterology January 24,2024
Could a high-fiber diet improve cancer immunotherapy performance?

Could a high-fiber diet improve cancer immunotherapy performance?

Could a high-fiber diet improve cancer immunotherapy performance?by Susanne Pallo,University of Rochester Medical CenterCredit: Foodie Factor from PexelsIt's no secret that a high-fiber diet
Gastroenterology January 24,2024
Could a high-fiber diet improve cancer immunotherapy performance?

Could a high-fiber diet improve cancer immunotherapy performance?

Could a high-fiber diet improve cancer immunotherapy performance?by Susanne Pallo,University of Rochester Medical CenterCredit: Foodie Factor from PexelsIt's no secret that a high-fiber diet
Gastroenterology January 24,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com